Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

APO-ACYCLOVIR TABLET 200 MG - HSA Drug Approval Details

Approvals/HSA/APO-ACYCLOVIR TABLET 200 MG

Approved

THERAPEUTIC

APO-ACYCLOVIR TABLET 200 MG

APOTEX INC (CANADA)🇸🇬 Health Sciences Authority

Approval Date: Oct 5, 1998
Approval ID: d2a802ac295787fe
Company: APOTEX INC (CANADA)
Type: Therapeutic

Approval Details

Approval Id: d2a802ac295787fe
Drug Name: APO-ACYCLOVIR TABLET 200 MG
Product Name: APO-ACYCLOVIR TABLET 200 MG
Approval Number: SIN10154P
Approval Date: 1998-10-05
Registrant: PHARMAFORTE SINGAPORE PTE LTD
Licence Holder: PHARMAFORTE SINGAPORE PTE LTD
Drug Type: Therapeutic
Forensic Classification: PRESCRIPTION ONLY MEDICINES
Dosage Form: TABLET
Route Of Administration: ORAL
Atc Code: J05AB01
Atc Item Name: aciclovir
Pharma Manufacturer Name: PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path: /organization/pharmaforte-singapore-pte-ltd

Active Ingredients

ACYCLOVIR

200 mg

ACYCLOVIR

200 mg

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Oct 5, 1998

Approval ID

d2a802ac295787fe

Type

Therapeutic

Back to HSA Approvals